A Study Of RPM Program For Pediatric Febrile Neutropenia

Overview

About this study

The purpose of this study is to implement an RPM program for PFN, assess initial efficacy and safety of this program, and gather information for future implementation scale-up and evaluation.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with cancer who receive care for a malignancy at Mayo Clinic Children’s and have been evaluated for fever

 Exclusion Criteria:

  • None

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 8/19/2025. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Open for enrollment

Contact information:

Kayla Weber

(507) 538-6743

couillard.kayla@mayo.edu

La Crosse, Wis.

Mayo Clinic principal investigator

Open for enrollment

Contact information:

Kayla Weber

(507) 538-6743

couillard.kayla@mayo.edu

More information

Publications

Publications are currently not available